TransEnterix

At TransEnterix, our vision is to improve clinical outcomes and patient care through the use of robotics in surgery. We seek to enhance and support surgeon capabilities while reducing the barriers to adoption with responsible economics and leveraging existing laparoscopic skills. SurgiBot™ and ALF-X® create a robotics portfolio that allows us to offer both a single-port and a multi-port platform. Our technology utilizes robotic assistance to enhance surgery with precision, dexterity, vision and ergonomics. Both platforms are designed to utilize laparoscopic experience while addressing the cost barriers of robotic surgery. The combined offerings of SurgiBot and ALF-X allow TransEnterix to address a broad range of procedures, facilities and geographies with compelling patient, surgeon and hospital value. SurgiBot™ and ALF-X® create a robotics portfolio that allows us to offer both a single-port and a multi-port platform. Our technology utilizes robotic assistance to enhance surgery with precision, dexterity, vision and ergonomics. Both platforms are designed to utilize laparoscopic experience while addressing the cost barriers of robotic surgery. The combined offerings of SurgiBot and ALF-X allow TransEnterix to address a broad range of procedures, facilities and geographies with compelling patient, surgeon and hospital value. The SurgiBot System is not available for sale in any market. The ALF-X has received the CE mark but is not available for sale in the U.S.
Company growth
Type
Public
HQ
Morrisville, US
Founded
2006
Size (employees)
130 (est)+33%
TransEnterix was founded in 2006 and is headquartered in Morrisville, US

Key People at TransEnterix

Todd M. Pope

Todd M. Pope

President & CEO
David N. Gill

David N. Gill

CFO
Richard M Mueller

Richard M Mueller

Chief Operating Officer
Jane H. Hsiao

Jane H. Hsiao

Chairman of the Board
Charles J. Filipi

Charles J. Filipi

M.D.
Jeffrey G

Jeffrey G

Spragens

TransEnterix Office Locations

TransEnterix has offices in Morrisville, Trezzano Rosa
Morrisville, US
Trezzano Rosa, IT

TransEnterix Metrics

TransEnterix Summary

Market capitalization

$151 M

Closing share price

$1.32
TransEnterix's current market capitalization is $151 M.

TransEnterix Financials

TransEnterix's revenue is $401 K in FY, 2014
FY, 2015FY, 2014FY, 2013

Revenue

$401 K$1.43 M

Revenue growth, %

-72.0%

Gross profit

$-694 K$-3.38 M

Operating income

$-46.4 M$-36.6 M$-25.6 M

Operating expense total

$46.4 M$35.9 M$22.2 M

Net Income

$-46.9 M$-37.7 M$-28.4 M

Operating cash flow

$3.68 M$24.8 M$1.12 M

TransEnterix Market Value History

TransEnterix Online Presence

TransEnterix Company Life

You may also be interested in